Iryna Kolosenko

534 total citations
19 papers, 383 citations indexed

About

Iryna Kolosenko is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Iryna Kolosenko has authored 19 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Immunology. Recurrent topics in Iryna Kolosenko's work include Cytokine Signaling Pathways and Interactions (7 papers), Acute Myeloid Leukemia Research (3 papers) and interferon and immune responses (3 papers). Iryna Kolosenko is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Acute Myeloid Leukemia Research (3 papers) and interferon and immune responses (3 papers). Iryna Kolosenko collaborates with scholars based in Sweden, United States and Italy. Iryna Kolosenko's co-authors include Dan Grandér, Katja Pokrovskaja Tamm, Caroline Palm‐Apergi, Angelo De Milito, Jenny Viklund, Nicola Baldini, Sofia Avnet, Linda Vidarsdóttir, Alireza Azimi and Ann‐Charlotte Björklund and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Iryna Kolosenko

17 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iryna Kolosenko Sweden 11 237 116 91 68 50 19 383
Carolina Hassibe Thomé Brazil 14 308 1.3× 112 1.0× 129 1.4× 67 1.0× 29 0.6× 30 482
Aditi Sharma United States 9 263 1.1× 172 1.5× 110 1.2× 81 1.2× 28 0.6× 14 471
Marta Stasiak Poland 13 259 1.1× 98 0.8× 82 0.9× 76 1.1× 121 2.4× 19 501
Giulia Biondani Italy 9 283 1.2× 171 1.5× 182 2.0× 42 0.6× 23 0.5× 9 461
Miaorong She China 10 254 1.1× 118 1.0× 48 0.5× 38 0.6× 29 0.6× 15 389
Silvia Grassilli Italy 14 308 1.3× 166 1.4× 154 1.7× 46 0.7× 18 0.4× 38 493
Huiling Zhou China 12 292 1.2× 86 0.7× 99 1.1× 43 0.6× 30 0.6× 22 375
Lalita Yadav India 5 213 0.9× 134 1.2× 153 1.7× 30 0.4× 27 0.5× 13 407

Countries citing papers authored by Iryna Kolosenko

Since Specialization
Citations

This map shows the geographic impact of Iryna Kolosenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iryna Kolosenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iryna Kolosenko more than expected).

Fields of papers citing papers by Iryna Kolosenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iryna Kolosenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iryna Kolosenko. The network helps show where Iryna Kolosenko may publish in the future.

Co-authorship network of co-authors of Iryna Kolosenko

This figure shows the co-authorship network connecting the top 25 collaborators of Iryna Kolosenko. A scholar is included among the top collaborators of Iryna Kolosenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iryna Kolosenko. Iryna Kolosenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Shah, Kinjal, Mehreen Ahmed, Wondossen Sime, et al.. (2023). PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia. Blood Cancer Journal. 13(1). 139–139. 6 indexed citations
4.
Kolosenko, Iryna, et al.. (2021). RNAi prodrugs decrease elevated mRNA levels of Polo‐like kinase 1 in ex vivo cultured primary cells from pediatric acute myeloid leukemia patients. The FASEB Journal. 35(5). e21476–e21476. 5 indexed citations
5.
Kolosenko, Iryna, Elena Kunold, Linda Vidarsdóttir, et al.. (2021). Thermal proteome profiling identifies PIP4K2A and ZADH2 as off‐targets of Polo‐like kinase 1 inhibitor volasertib. The FASEB Journal. 35(7). e21741–e21741. 4 indexed citations
6.
Vidarsdóttir, Linda, Ann‐Charlotte Björklund, Alexander Hamil, et al.. (2020). Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients. Scientific Reports. 10(1). 2688–2688. 10 indexed citations
7.
Wang, Qian, Martin Haraldsson, Belén Espinosa, et al.. (2020). Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death. Science Advances. 6(12). eaax7945–eaax7945. 50 indexed citations
8.
Vidarsdóttir, Linda, et al.. (2019). Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western Blot. Methods in molecular biology. 2036. 53–72. 2 indexed citations
9.
Kolosenko, Iryna, et al.. (2019). STAT3 is activated in multicellular spheroids of colon carcinoma cells and mediates expression of IRF9 and interferon stimulated genes. Scientific Reports. 9(1). 536–536. 10 indexed citations
10.
Desroses, Matthieu, Juan Astorga‐Wells, Iryna Kolosenko, et al.. (2018). STAT3 differential scanning fluorimetry and differential scanning light scattering assays: Addressing a missing link in the characterization of STAT3 inhibitor interactions. Journal of Pharmaceutical and Biomedical Analysis. 160. 80–88. 15 indexed citations
11.
Pellegrini, Paola, Thomas Lundbäck, Magdalena Mazurkiewicz, et al.. (2018). A drug screening assay on cancer cells chronically adapted to acidosis. Cancer Cell International. 18(1). 147–147. 19 indexed citations
12.
Kolosenko, Iryna, et al.. (2018). Polo-like kinases and acute leukemia. Oncogene. 38(1). 1–16. 55 indexed citations
13.
Kolosenko, Iryna, Ann‐Charlotte Björklund, Alexander Hamil, et al.. (2017). RNAi prodrugs targeting Plk1 induce specific gene silencing in primary cells from pediatric T-acute lymphoblastic leukemia patients. Journal of Controlled Release. 261. 199–206. 15 indexed citations
14.
Kolosenko, Iryna, Sofia Avnet, Nicola Baldini, Jenny Viklund, & Angelo De Milito. (2017). Therapeutic implications of tumor interstitial acidification. Seminars in Cancer Biology. 43. 119–133. 77 indexed citations
15.
Kolosenko, Iryna, Matheus Dyczynski, Jianping Liu, et al.. (2017). Identification of novel small molecules that inhibit STAT3-dependent transcription and function. PLoS ONE. 12(6). e0178844–e0178844. 18 indexed citations
16.
Kolosenko, Iryna, Dan Grandér, & Katja Pokrovskaja Tamm. (2014). IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma. Current Medicinal Chemistry. 21(26). 3042–3047. 38 indexed citations
17.
Kolosenko, Iryna, Mårten Fryknäs, Per Johnsson, et al.. (2014). Cell crowding induces interferon regulatory factor 9, which confers resistance to chemotherapeutic drugs. International Journal of Cancer. 136(4). E51–61. 27 indexed citations
18.
Lin, Huiqiong, Iryna Kolosenko, Ann‐Charlotte Björklund, et al.. (2012). An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma. Experimental Cell Research. 319(5). 600–611. 13 indexed citations
19.
Arulampalam, Velmurugesan, et al.. (2010). Activation of STAT1 is required for interferon-alpha-mediated cell death. Experimental Cell Research. 317(1). 9–19. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina Hassibe Thomé Breakdown of academic impact, for papers by Aditi Sharma Breakdown of academic impact, for papers by Marta Stasiak Breakdown of academic impact, for papers by Giulia Biondani Breakdown of academic impact, for papers by Miaorong She Breakdown of academic impact, for papers by Silvia Grassilli Breakdown of academic impact, for papers by Huiling Zhou Breakdown of academic impact, for papers by Lalita Yadav
Rankless by CCL
2026